75 related articles for article (PubMed ID: 30260155)
21. A new player in IDH1 mutated myeloid neoplasias.
Heuser M
Lancet Haematol; 2023 Jan; 10(1):e7-e8. PubMed ID: 36566048
[No Abstract] [Full Text] [Related]
22. IDH1 inhibitor shows promising early results.
Cancer Discov; 2015 Jan; 5(1):4. PubMed ID: 25583779
[TBL] [Abstract][Full Text] [Related]
23. Low prevalence of IDH1 gene mutation in childhood AML in Italy.
Pigazzi M; Ferrari G; Masetti R; Falini B; Martinolli F; Basso G; Biondi A; Pession A; Cazzaniga G
Leukemia; 2011 Jan; 25(1):173-4. PubMed ID: 20944672
[No Abstract] [Full Text] [Related]
24. [Detection of isocitrate dehydrogenase 1 gene mutation in 205 AML patients and its clinical significance].
Shang Z; Wang D; Xiao M; Geng Z; Wang HX; Wang J; Xu YL; Li TJ; Zhou JF; Li CR
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Dec; 20(6):1307-11. PubMed ID: 23257422
[TBL] [Abstract][Full Text] [Related]
25. Evidence for Clinical Differentiation and Differentiation Syndrome in Patients With Acute Myeloid Leukemia and IDH1 Mutations Treated With the Targeted Mutant IDH1 Inhibitor, AG-120.
Birendra KC; DiNardo CD
Clin Lymphoma Myeloma Leuk; 2016 Aug; 16(8):460-5. PubMed ID: 27245312
[TBL] [Abstract][Full Text] [Related]
26. Detection of IDH1 R132H mutation in acute myeloid leukemia by mutation-specific immunohistochemistry.
Byers R; Hornick JL; Tholouli E; Kutok J; Rodig SJ
Appl Immunohistochem Mol Morphol; 2012 Jan; 20(1):37-40. PubMed ID: 22172803
[TBL] [Abstract][Full Text] [Related]
27. Detection of FLT3/TKD and IDH1 Mutations in Pakistani Acute Myeloid Leukemia Patients by Denaturing HPLC.
Ali A; Gale RE; Shakoori AR
J Cell Biochem; 2017 May; 118(5):1174-1181. PubMed ID: 27735988
[TBL] [Abstract][Full Text] [Related]
28. Persistence of mutant isocitrate dehydrogenase in patients with acute myeloid leukemia in remission.
Chou WC; Peng KY; Lei WC; Ko BS; Tsay W; Kuo CH; Tien HF
Leukemia; 2012 Mar; 26(3):527-9. PubMed ID: 21844873
[No Abstract] [Full Text] [Related]
29. A Zebrafish Model for Evaluating the Function of Human Leukemic Gene IDH1 and Its Mutation.
Ma ACH; Shi X; He BL; Guo Y; Leung AYH
Methods Mol Biol; 2017; 1633():193-218. PubMed ID: 28735489
[TBL] [Abstract][Full Text] [Related]
30. [IDH gene mutations and acute myeloid leukemia].
Sun C; Zhang SJ; Li JY
Zhonghua Xue Ye Xue Za Zhi; 2013 Mar; 34(3):273-5. PubMed ID: 23683434
[No Abstract] [Full Text] [Related]
31. Therapeutic targeting of isocitrate dehydrogenase mutant AML.
Boddu P; Borthakur G
Expert Opin Investig Drugs; 2017 May; 26(5):525-530. PubMed ID: 28388242
[No Abstract] [Full Text] [Related]
32. Somatic mosaic mutations of IDH1 and NPM1 associated with cup-like acute myeloid leukemia in a patient with Maffucci syndrome.
Akiyama M; Yamaoka M; Mikami-Terao Y; Ohyama W; Yokoi K; Arakawa Y; Takita J; Suzuki H; Yamada H
Int J Hematol; 2015 Dec; 102(6):723-8. PubMed ID: 26508204
[TBL] [Abstract][Full Text] [Related]
33. Molecular predictors of response and survival following IDH1/2 inhibitor monotherapy in acute myeloid leukemia.
Gangat N; McCullough K; Abdelmagid M; Karrar O; Powell M; Al-Kali A; Alkhateeb H; Begna K; Mangaonkar A; Saliba A; Torghabeh MH; Litzow M; Hogan W; Shah M; Patnaik M; Pardanani A; Badar T; Foran J; Palmer J; Sproat L; Yi CA; Tefferi A
Haematologica; 2024 Jan; 109(1):187-292. PubMed ID: 37534525
[No Abstract] [Full Text] [Related]
34. [Clinical characteristics of newly diagnosed acute myeloid leukemia patients with NPM1 mutation].
Wei H; Zhang YQ; Lin D; Wang Y; Zhou CL; Liu BC; Li W; Rao Q; Wang M; Mi YC; Wang JX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Feb; 22(1):11-5. PubMed ID: 24598642
[TBL] [Abstract][Full Text] [Related]
35. Impact of IDH1 R132 mutations and an IDH1 single nucleotide polymorphism in cytogenetically normal acute myeloid leukemia: SNP rs11554137 is an adverse prognostic factor.
Wagner K; Damm F; Göhring G; Görlich K; Heuser M; Schäfer I; Ottmann O; Lübbert M; Heit W; Kanz L; Schlimok G; Raghavachar AA; Fiedler W; Kirchner HH; Brugger W; Zucknick M; Schlegelberger B; Heil G; Ganser A; Krauter J
J Clin Oncol; 2010 May; 28(14):2356-64. PubMed ID: 20368538
[TBL] [Abstract][Full Text] [Related]
36. Prognostic impact of the isocitrate dehydrogenase 1 single-nucleotide polymorphism rs11554137 in malignant gliomas.
Wang XW; Boisselier B; Rossetto M; Marie Y; Idbaih A; Mokhtari K; Gousias K; Hoang-Xuan K; Delattre JY; Simon M; Labussière M; Sanson M
Cancer; 2013 Feb; 119(4):806-13. PubMed ID: 23184331
[TBL] [Abstract][Full Text] [Related]
37. Clinical Utility of Ivosidenib in the Treatment of IDH1-Mutant Cholangiocarcinoma: Evidence To Date.
Uson Junior PLS; Borad MJ
Cancer Manag Res; 2023; 15():1025-1031. PubMed ID: 37746315
[TBL] [Abstract][Full Text] [Related]
38. [Research advances of IDH gene mutation and AML].
Sun MD; Zheng YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1485-9. PubMed ID: 25338613
[TBL] [Abstract][Full Text] [Related]
39. Durable response to ivosidenib in post-transplant relapse and leukemic transformation of myelodysplastic syndrome with new complex karyotype and
Alkhaldi H; Sewell D; Ning Y; Kallen ME; Emadi A; Hardy NM; Baer MR
Leuk Lymphoma; 2022 Dec; 63(12):3000-3003. PubMed ID: 35938721
[TBL] [Abstract][Full Text] [Related]
40. Ivosidenib combination improves OS.
Killock D
Nat Rev Clin Oncol; 2022 Jul; 19(7):427. PubMed ID: 35534622
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
